<?xml version="1.0" encoding="UTF-8"?>
<document id="29045821">
	<sentence id="s1" text="MiR-93-5p has been previously found to be associated with gastric cancer (GC) tumorigenesis; however, the current understanding of its function in this context remains largely incomplete.">
		<entity id="s1.e1" charOffset="66-72"
			type="HP" text="cancer" ontology_id="HP_0002664"/>
		<entity id="s1.e2" charOffset="74-76"
			type="GENE" text="GC" ontology_id="2638"/>
		<entity id="s1.e3" charOffset="78-83"
			type="HP" text="tumor" ontology_id="HP_0002664"/>
		<pair id="s1.p1" e1="s1.e1"
		    e2="s1.e2" pgr="false"/>
		<pair id="s1.p2" e1="s1.e2"
		    e2="s1.e3" pgr="false"/>
	</sentence>
	<sentence id="s2" text="MiR-93-5p upregulation was also shown to inhibit the expression of two well-characterized Hippo pathway regulators, protocadherin Fat 4 (FAT4), and large tumor suppressors 2 (LATS2), at both the mRNA and protein level.">
		<entity id="s2.e1" charOffset="130-133"
			type="GENE" text="Fat" ontology_id="948"/>
		<entity id="s2.e2" charOffset="137-141"
			type="GENE" text="FAT4" ontology_id="79633"/>
		<entity id="s2.e3" charOffset="154-159"
			type="HP" text="tumor" ontology_id="HP_0002664"/>
		<entity id="s2.e4" charOffset="175-180"
			type="GENE" text="LATS2" ontology_id="26524"/>
		<pair id="s2.p1" e1="s2.e1"
		    e2="s2.e3" pgr="false"/>
		<pair id="s2.p2" e1="s2.e2"
		    e2="s2.e3" pgr="true"/>
		<pair id="s2.p3" e1="s2.e3"
		    e2="s2.e4" pgr="false"/>
	</sentence>
</document>
